Development of advanced MRI biomarker technologies
Center Administration
['FUNDING_OTHER'] · HUGO W. MOSER RES INST KENNEDY KRIEGER · NIH-11112347
This study is all about developing new MRI tools that help doctors better understand health conditions, so patients can get more accurate diagnoses and better care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | HUGO W. MOSER RES INST KENNEDY KRIEGER (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11112347 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and sharing innovative MRI biomarker technologies that enhance the understanding of physiological, metabolic, and anatomical conditions. It involves a collaborative effort among experts in magnetic resonance technology, who will develop fast imaging and spectroscopy techniques. Patients may benefit from improved diagnostic tools that provide more accurate assessments of their health conditions. The project also includes training for clinicians and researchers on how to effectively use these new technologies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals undergoing MRI scans for various health conditions that require detailed physiological and anatomical analysis.
Not a fit: Patients who do not require MRI imaging or those with conditions that do not involve physiological or anatomical biomarkers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and efficient diagnostic tools for various medical conditions.
How similar studies have performed: Previous research in MRI biomarker development has shown promising results, indicating that this approach has the potential for significant advancements in medical imaging.
Where this research is happening
BALTIMORE, UNITED STATES
- HUGO W. MOSER RES INST KENNEDY KRIEGER — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VAN ZIJL, PETER CM — HUGO W. MOSER RES INST KENNEDY KRIEGER
- Study coordinator: VAN ZIJL, PETER CM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.